Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Anticipate generic drug launch
Proactively manage your pharmacy inventory
Manage your formulary budget
Find generic entry opportunities
Drug patents …
… from Kazakhstan to Kalamazoo
|Title:||Controlled-release multiple units pharmaceutical formulation|
|Abstract:||A pharmaceutical controlled-release individual unit or multiple units formulation in which the individual unit comprises a granulation product obtained by adding a release controlling agent to a mixture of a physiologically active substance and units-forming substance(s) and granulating and resultant mixture, said granulation product (granules) being substantially not disintegrated but gradually releasing the physiologically active substance in the gastrointestinal tract.|
|Inventor(s):||Fukui; Muneo (Saitama, JP), Tomuro; Kouji (Saitama, JP), Masuyama; Shigeru (Saitama, JP), Kajiyama; Atsushi (Saitama, JP), Hikosaka; Tamio (Saitama, JP), Aruga; Masayoshi (Saitama, JP), Higuchi; Saburo (Saitama, JP), Soeishi; Yoshiaki (Tokyo, JP)|
|Assignee:||Yamanouchi Pharmaceutical Co., Ltd. (Tokyo, JP)|
Patent Claim Types:|
see list of patent claims
|Foriegn Application Priority Data|
|Foreign Country||Foreign Patent Number||Foreign Patent Date|
|Japan||60-46180||Mar 08, 1985|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.